Real world time trends in antithrombotic treatment for newly diagnosed atrial fibrillation in China: reports from the GLORIA-AF Phase III registry: Trends in antithrombotic therapy use in China

BACKGROUND: Stroke prevention with oral anticoagulant (OAC) therapy, including non-vitamin K antagonist oral anticoagulants (NOACs), is recommended in patients with atrial fibrillation (AF). This analysis describes the antithrombotic prescription patterns for Chinese patients enrolled post-dabigatra...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xiaoxia, Feng, Guoze, Marler, Sabrina Vogel, Huisman, Menno V, Lip, Gregory Y. H., Ma, Changsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394786/
https://www.ncbi.nlm.nih.gov/pubmed/37528405
http://dx.doi.org/10.1186/s12959-023-00527-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394786/
https://www.ncbi.nlm.nih.gov/pubmed/37528405
http://dx.doi.org/10.1186/s12959-023-00527-x

Ejemplares similares